Bero comments on corporate funding and academic research
Lisa Bero, PhD, UCSF School of Pharmacy faculty member, looks at the potential benefits, risks, and ethical issues of different corporate/academic funding models. She also calls for a research agenda aimed at clarifying the effects of these relationships on research integrity, faculty attitudes, technology transfer, and research productivity. Her comments appear in the June 4, 2008 online version of the Journal of Epidemiology under the title "'Experimental institutional' models for corporate funding of academic research: Unknown effects on the research enterprise."